NCT04822636 · University of California, San Francisco
Family Mental Health Family Navigator Project (FMHN)
(FMHN)
What this study is about
This study will focus on developing and testing a family-based mental health navigator intervention, the Family Mental Health Navigator (FMHN), to evaluate whether the intervention combined with mHealth is preliminary efficacious in improving mental health service initiation and engagement for publicly-insured youth.
View original scientific description
This study will focus on developing and testing a family-based mental health navigator intervention, the Family Mental Health Navigator (FMHN), to evaluate whether the intervention combined with mHealth is preliminary efficacious in improving mental health service initiation and engagement for publicly-insured youth.
Interventions
BEHAVIORAL
Family-based mental health navigation
Family-based navigator intervention combined with mHealth practices to improve mental health treatment initiation and engagement
Primary outcome measures
Time to treatment referral
Time frame: 12 months post enrollment
Number of days until treatment referral is made
Time to treatment initiation
Time frame: 12 months post enrollment
Number of days until attendance at first treatment session
Treatment engagement
Time frame: 12 months post enrollment
Engagement as measured by attendance in treatment for 6 or more weeks
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- English-speaking and/or Spanish-speaking youth
- Are currently receiving services at the San Francisco General Hospital
- Are publicly insured
- Have an involved caregiver/legal guardian for consent
- Family has mobile phone access
Exclusion criteria
- Youth is not English-speaking nor Spanish-speaking
- Caregiver has impairment that would preclude providing informed consent
- Unavailable guardian for consent
Where
- San Francisco, California
Collaborators
San Francisco General Hospital Foundation
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 7, 2025 · Source of record for eligibility and locations